Literature DB >> 24682634

How to distinguish tumor growth from transient expansion of vestibular schwannomas following Gamma Knife radiosurgery.

Thomas Mindermann1, Ines Schlegel.   

Abstract

BACKGROUND: Typically, vestibular schwannomas (VS) react to Gamma Knife radiosurgery (GKRS) with a transient increase of tumor volume owed to tumor swelling at about 6 months followed by a reduction of tumor volume owed to tumor shrinkage at about 18 months. It is important to distinguish this transient tumor expansion (TTE) from tumor growth. We undertook this study to see if there is a typical time interval in the follow-up of VS following GKRS, which may indicate tumor growth rather than TTE.
METHODS: We retrospectively reviewed the patient charts of patients who underwent GKRS for unilateral sporadic VS at the Gamma Knife Center Zurich from 1994-2009 and who were treated by J. Siegfried or one of the authors (TM). Tumor progression was defined as an increase of tumor volume of ≥ 20 % as compared to the initial tumor volume at the earliest 2 years following GKRS. This time interval of ≥ 2 years was chosen in order to distinguish TTE from genuine tumor progression. Whenever tumor enlargement was suspected on follow-up MRI at ≥ 2 years following GKRS, tumor volumes were measured using custom software.
RESULTS: From 1994-2009, 235 patients underwent GKRS in Zurich for unilateral sporadic VS. Tumor progression with a volume increase of ≥ 20 % occurred in 21/235 (8.9 %) patients at 3.4 ± 0.9 years following GKRS. Seventeen out of 235 (7 %) patients had a clinically relevant tumor progression requiring microsurgery or repeat radiosurgery.
CONCLUSIONS: According to our data, time may be a good parameter distinguishing tumor progression due to tumor growth from TTE due to tumor swelling in VS following GKRS. Tumor growth seems to occur at about 3-4 years following GKRS for VS as opposed to TTE, which seems to be present at about 6-18 months following GKRS for VS.

Entities:  

Mesh:

Year:  2014        PMID: 24682634     DOI: 10.1007/s00701-014-2063-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  13 in total

1.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

2.  Long-term outcomes of stereotactic radiosurgery for skull base tumors involving the cavernous sinus.

Authors:  Motoyuki Umekawa; Yuki Shinya; Hirotaka Hasegawa; Masahiro Shin; Mariko Kawashima; Atsuto Katano; Nobuhito Saito
Journal:  J Neurooncol       Date:  2022-01-14       Impact factor: 4.130

3.  Vestibular Schwannoma Tumor Size and Growth Rate Predict Response with Gamma Knife Stereotactic Radiosurgery.

Authors:  Daniel E Killeen; Anthony M Tolisano; Brandon Isaacson; J Walter Kutz; Samuel Barnett; Zabi Wardak; Jacob B Hunter
Journal:  J Neurol Surg B Skull Base       Date:  2020-10-05

4.  Gamma Knife Radiosurgery for Large Vestibular Schwannoma More Than 10 cm 3 : A Single-Center Indian Study.

Authors:  Ujwal Yeole; A R Prabhuraj; Arimappamagan Arivazhagan; K V L Narasingarao; Vikas Vazhayil; Dhananjaya Bhat; Dwarakanath Srinivas; Bhanumathi Govindswamy; Somanna Sampath
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-23

5.  Stereotactic radiotherapy for large vestibular schwannomas: Volume change following single fraction versus hypofractionated approaches.

Authors:  Michael Huo; Heath Foley; Mark Pinkham; Mihir Shanker; Anne Bernard; Michael Jenkins; Sarah Olson; Bruce Hall; Trevor Watkins; Catherine Jones; Matthew Foote
Journal:  J Radiosurg SBRT       Date:  2020

Review 6.  Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.

Authors:  Oscar Persson; Jiri Bartek; Netanel Ben Shalom; Theresa Wangerid; Asgeir Store Jakola; Petter Förander
Journal:  Acta Neurochir (Wien)       Date:  2017-04-13       Impact factor: 2.216

7.  Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma.

Authors:  Yuki Shinya; Hirotaka Hasegawa; Masahiro Shin; Takehiro Sugiyama; Mariko Kawashima; Wataru Takahashi; Shinichi Iwasaki; Akinori Kashio; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2019-10-07       Impact factor: 6.639

8.  Repeat Gamma Knife surgery for vestibular schwannomas.

Authors:  Sarah Lonneville; Carine Delbrouck; Cécile Renier; Daniel Devriendt; Nicolas Massager
Journal:  Surg Neurol Int       Date:  2015-09-28

9.  Preserving normal facial nerve function and improving hearing outcome in large vestibular schwannomas with a combined approach: planned subtotal resection followed by gamma knife radiosurgery.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Marc Levivier
Journal:  Acta Neurochir (Wien)       Date:  2017-05-17       Impact factor: 2.216

10.  Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system.

Authors:  Daniel Rueß; Lea Pöhlmann; Stefan Grau; Christina Hamisch; Mauritius Hoevels; Harald Treuer; Christian Baues; Martin Kocher; Maximillian Ruge
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.